BioCentury
ARTICLE | Clinical News

Gensia Inc. regulatory update

April 10, 1995 7:00 AM UTC

GNSA's Gensia Laboratories Ltd. subsidiary received FDA approval of its ANDA for a generic version of injectable amphotericin B to treat fungal infections. Gensia Laboratories (Irvine, Calif.) now has...